Lithium hexamethyl disilazide solution - 1 M in tert-butyl methyl ether
CAS :
Ref. 3D-FL146829
Informations sur le produit
Nom:Lithium hexamethyl disilazide solution - 1 M in tert-butyl methyl ether
Synonymes :
- 1,1,1,3,3,3-Hexamethyldisilazane lithium saltLithium bis(trimethylsilyl)amide
Marque:Biosynth
Description :Lithium hexamethyl disilazide solution is an inhibitor drug that blocks the synthesis of pyrimidine compounds. It has been shown to be effective in congestive heart failure, hyperproliferative diseases such as pancreatitis and dyslipoproteinemia, coronary heart diseases, and HIV infection. Lithium hexamethyl disilazide solution binds to the cb2 receptor on the surface of activated T cells, which inhibits their ability to cause inflammation or autoimmune disease. This drug also has nitrogen atoms that are reactive and asymmetric, making it a good candidate for an inhibitor drug.
Avis:Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Propriétés chimiques
Masse moléculaire :167.33 g/mol
Formule :C6H18LiNSi2
Degré de pureté :Min. 95%